SuperworthAngiodynamics EPS ANGO
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Aug 31, 2026
- −$0.78
- Latest quarter, Q1 FY27
- −$0.17
- Fiscal year 2026
- −$0.87
Angiodynamics' earnings per share was −$0.78 over the twelve months to Aug 31, 2026.
In its latest quarter, Q1 FY27, it was −$0.17.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | −$0.87 | n/a |
| FY2025 | −$0.83 | n/a |
| FY2024 | −$4.57 | n/a |
| FY2023 | −$1.32 | n/a |
| FY2022 | −$0.68 | n/a |
| FY2021 | −$0.82 | n/a |
| FY2020 | −$4.39 | −373% |
| FY2019 | $1.61 | +266% |
| FY2018 | $0.44 | +214% |
| FY2017 | $0.14 | n/a |
| FY2016 | −$1.20 | n/a |
| FY2015 | −$0.10 | −225% |
| FY2014 | $0.08 | n/a |
| FY2013 | −$0.03 | n/a |
| FY2012 | −$0.20 | −161% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q1 FY27 | −$0.17 | n/a | −$0.78 | |
| Q4 FY26 | −$0.27 | n/a | −$0.87 | |
| Q3 FY26 | −$0.19 | n/a | −$0.75 | |
| Q2 FY26 | −$0.15 | n/a | −$0.67 | |
| Q1 FY26 | −$0.26 | n/a | −$0.78 | |
| Q4 FY25 | −$0.15 | n/a | −$0.83 | |
| Q3 FY25 | −$0.11 | n/a | −$1.01 | |
| Q2 FY25 | −$0.26 | n/a | −$5.57 | |
| Q1 FY25 | −$0.31 | −127% | −$6.03 | |
| Q4 FY24 | −$0.33 | n/a | −$4.57 | |
| Q3 FY24 | −$4.67 | n/a | −$4.78 | |
| Q2 FY24 | −$0.72 | n/a | −$0.35 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Angiodynamics' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ANGOAngiodynamics | −$0.78 | |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MDXGMimedx | $0.04 | −81% a year |
| MOVMovado | $1.80 | +137% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| IRMDIradimed | $1.79 | +10% a year |
| STAAStaar Surgical | $0.07 | |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| BVSBioventus | $0.77 | |
| CDRECadre | $0.81 | −14% a year |
| Peer median | $0.94 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Angiodynamics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.